Korean Multicenter Registry of EPIC stent for Iliac Artery Disease: (K-EPIC Registry)
- Conditions
- Diseases of the circulatory system
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 150
1) Age 19 years of older
2) Symptomatic peripheral artery disease:
- Moderate or severe claudication (Rutherford category 2 or 3)
- Critical limb ischemia (Rutherford category 4)
3) Iliac artery lesions with stenosis > 50%
4) ABI <0.9
5) Patents treated with EPIC stent for femoropopliteal artery disease
6) Patients with signed informed consent
1) Acute critical limb ischemia
2) Severe critical limb ischemia (Rutherford category 5 or 6)
3) Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin,
clopidogrel, cilostazol, or contrast agents
4) In-stent restenosis lesions (Restenosis lesions without previously implanted stents are eligible to
the enrollment)
5) Bypass graft lesions
6) Age > 85 years
7) Severe hepatic dysfunction (> 3 times normal reference values)
8) Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis
9) LVEF < 40% or clinically overt congestive heart failure
10) Pregnant women or women with potential childbearing
11) Life expectancy <1 year due to comorbidity
12) Untreated proximal inflow disease of aorta or the ipsilateral iliac arteries (more than 50%
stenosis or occlusion)
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary patency
- Secondary Outcome Measures
Name Time Method Target lesion revascularization rate;Stent fracture rate;Quality of life by standardized questionnaires